You are here

  • Home
  • Archive
  • Volume 15, Issue 5
  • Primary percutaneous coronary intervention in ST-segment elevation myocardial infarction is more effective than fibrinolysis at reducing the composite outcome of death or reinfarction after 8 years

Article Text

Article menu
Download PDFPDF
Therapeutics
DANAMI-2 randomised controlled trial
Primary percutaneous coronary intervention in ST-segment elevation myocardial infarction is more effective than fibrinolysis at reducing the composite outcome of death or reinfarction after 8 years

https://doi.org/10.1136/ebm1108

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests AED received moderate grant support from PDL Biopharma for the AMICO trial.